MedPage Today on MSN3d
Brain Edema, Imaging Abnormalities Reported for Alzheimer's Drug
Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...
Fierce Pharma8d
In UK, it's strike 2 for Alzheimer's treatments from Lilly and Biogen/Eisai
England’s National Institute for Health and Care Excellence (NICE) has given a second thumbs down to a pair of Alzheimer’s ...
4BIIB, LLY : Alzheimer's Drugs From Eli Lilly And Biogen Still Deemed...
NICE has upheld its decision not to recommend Alzheimer's treatments donanemab and lecanemab for NHS use, citing high costs ...
‘Miracle’ Alzheimer’s drug ‘triggers deadly brain bleeds in up to a third’, new study finds
AN ALZHEIMER’S drug hailed as a ‘miracle’ medicine for dementia may cause life-threatening brain bleeds in a third of ...
pharmaphorum2d
Five takeaways from the new donanemab data
Headlines about the results of TRAILBLAZER-ALZ2 trial of Eli Lilly’s Alzheimer’s drug candidate donanemab are spreading around the world, with some going as far as to suggest this could herald ...
pharmaphorum5d
Lilly files Alzheimer's drug donanemab as Cortexyme rival fails trial
Eli Lilly has followed through on its plan to file for approval of its Alzheimer's disease candidate donanemab, and is planning to take on Biogen and Eisai with a head-to-head trial against their ...
Fresh warning over £60K 'miracle' Alzheimer's drug as study finds it could trigger brain bleeds in up to a third
A so-called 'miracle' Alzheimer's drug caused brain bleeds in more than a third of patients, a new study has revealed.
Daily Mail4d
Fresh warning over £60K 'miracle' Alzheimer's drug as study finds it could trigger brain bleeds in up to a third
Eli Lilly's senior medical director and associate vice president, respectively. 'Therefore, safety monitoring is necessary with donanemab.' The medication, which patients receive through a ...